Revolution Medicines, Inc. · NASDAQ:RVMD
Sandler Alan B. sold 6,309 Revolution Medicines, Inc. shares (Form 4)
Traded Sep 29, 2026 · Filed Oct 1, 2026
On Sep 29, 2026, Sandler Alan B. (Chief Development Officer) sold 6,309 Revolution Medicines, Inc. shares at an average US$202.14 for US$1.28M under a trading plan, leaving 52,559 shares. Filed Oct 1, 2026 (Form 4).
- Sold
- 6,309 shares
- Price
- US$202.14 average (US$200.82 to US$204.72)
- Value
- US$1.28M
- Holding after
- 52,559 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Common Stock | Option exercise | 6,000 | US$58.84 | 58,868 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 2,200 | US$200.82 | 56,668 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 1,609 | US$201.72 | 55,059 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 1,000 | US$202.81 | 54,059 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 1,199 | US$203.91 | 52,860 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 301 | US$204.72 | 52,559 | Direct |
Source
Related
- Revolution Medicines, Inc.
- Sandler Alan B.
- Revolution Medicines, Inc. shareholders
- Form 4 · Sandler Alan B. · Sep 18, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026
- Form 4 · Anders Jack · Sep 18, 2026